Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
De Berardis, Domenico
Tomasetti, Carmine
Pompili, Maurizio
Serafini, Gianluca
Vellante, Federica
Fornaro, Michele
Valchera, Alessandro
Perna, Giampaolo
Volpe, Umberto
Martinotti, Giovanni
Fraticelli, Silvia
Di Giannantonio, Massimo
Kim, Yong-Ku
and
Orsolini, Laura
2020.
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine.
Current Topics in Medicinal Chemistry,
Vol. 20,
Issue. 7,
p.
554.
Shindyapina, Nataliya V.
Marshalov, D. V.
Shifman, E. M.
and
Kuligin, A. V.
2020.
Clinical effects of low-dose intravenous ketamine in obstetrics: a systematic review.
Annals of Critical Care,
p.
104.
Wang, Ya-Ting
Wang, Xiao-Le
Feng, Si-Tong
Chen, Nai-Hong
Wang, Zhen-Zhen
and
Zhang, Yi
2021.
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression.
Pharmacological Research,
Vol. 171,
Issue. ,
p.
105761.
Sanches, Marsal
Quevedo, Joao
and
Soares, Jair C.
2021.
New agents and perspectives in the pharmacological treatment of major depressive disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 106,
Issue. ,
p.
110157.
Brietzke, Elisa M.
Mansur, Rodrigo B.
Gomes, Fabiano A.
and
McIntyre, Roger S.
2021.
Ketamine for Treatment-Resistant Depression.
p.
139.
Grotell, Milo
Abdurakhmanova, Shamsiiat
Elsilä, Lauri V.
and
Korpi, Esa R.
2021.
Mice Lacking GABAA Receptor δ Subunit Have Altered Pharmaco-EEG Responses to Multiple Drugs.
Frontiers in Pharmacology,
Vol. 12,
Issue. ,
McIntyre, Roger S.
Rodrigues, Nelson B.
Lipsitz, Orly
Lee, Yena
Cha, Danielle S.
Gill, Hartej
Lui, Leanna M.W.
Subramaniapillai, Mehala
Kratiuk, Kevin
Ho, Roger
Mansur, Rodrigo B.
and
Rosenblat, Joshua D.
2021.
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment.
Journal of Affective Disorders,
Vol. 288,
Issue. ,
p.
210.
McIntyre, Roger S.
Lipsitz, Orly
Lui, Leanna M.W.
Rodrigues, Nelson B.
Gill, Hartej
Nasri, Flora
Ling, Rui
Teopiz, Kayla M.
Ho, Roger C.
Subramaniapillai, Mehala
Kratiuk, Kevin
Mansur, Rodrigo B.
Jones, Brett D.M.
Lee, Yena
and
Rosenblat, Joshua D.
2021.
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
Journal of Affective Disorders,
Vol. 294,
Issue. ,
p.
592.
Li, Hongmin
Sheng, Zhaofu
Khan, Suliman
Zhang, Ruiyi
Liu, Yang
Zhang, Yan
Yong, V. Wee
and
Xue, Mengzhou
2022.
Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression.
Frontiers in Neurology,
Vol. 13,
Issue. ,
Rodrigues, Nelson B.
McIntyre, Roger S.
Lipsitz, Orly
Cha, Danielle S.
Cao, Bing
Lee, Yena
Gill, Hartej
Lui, Leanna M. W.
Cubała, Wiesław J.
Ho, Roger
Shekotikhina, Margarita
Teopiz, Kayla M.
Subramaniapillai, Mehala
Kratiuk, Kevin
Mansur, Rodrigo B.
and
Rosenblat, Joshua D.
2022.
Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?.
Journal of Sleep Research,
Vol. 31,
Issue. 1,
Rossetti, Clara
Cherix, Antoine
Guiraud, Laetitia F.
and
Cardinaux, Jean-René
2022.
New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.
Frontiers in Molecular Neuroscience,
Vol. 15,
Issue. ,
Della Vecchia , Alessandra
Arone, Alessandro
Piccinni , Armando
Mucci, Federico
and
Marazziti, Donatella
2022.
GABA System in Depression: Impact on Pathophysiology and Psychopharmacology.
Current Medicinal Chemistry,
Vol. 29,
Issue. 36,
p.
5710.
Poznanski, Alexander J.
and
Akinyemi, Esther
2022.
Recent Advances in Psychopharmacology.
Advances in Psychiatry and Behavioral Health,
Vol. 2,
Issue. 1,
p.
253.
Sampogna, Gaia
Di Vincenzo, Matteo
Giallonardo, Vincenzo
Luciano, Mario
and
Fiorillo, Andrea
2022.
Recovery and Major Mental Disorders.
Vol. 2,
Issue. ,
p.
245.
McIntyre, Roger S.
Alsuwaidan, Mohammad
Baune, Bernhard T.
Berk, Michael
Demyttenaere, Koen
Goldberg, Joseph F.
Gorwood, Philip
Ho, Roger
Kasper, Siegfried
Kennedy, Sidney H.
Ly‐Uson, Josefina
Mansur, Rodrigo B.
McAllister‐Williams, R. Hamish
Murrough, James W.
Nemeroff, Charles B.
Nierenberg, Andrew A.
Rosenblat, Joshua D.
Sanacora, Gerard
Schatzberg, Alan F.
Shelton, Richard
Stahl, Stephen M.
Trivedi, Madhukar H.
Vieta, Eduard
Vinberg, Maj
Williams, Nolan
Young, Allan H.
and
Maj, Mario
2023.
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions.
World Psychiatry,
Vol. 22,
Issue. 3,
p.
394.
Witkin, Jeffrey M
Golani, Lalit K
and
Smith, Jodi L
2023.
Clinical pharmacological innovation in the treatment of depression.
Expert Review of Clinical Pharmacology,
Vol. 16,
Issue. 4,
p.
349.
Gonda, Xenia
Tarazi, Frank I.
and
Dome, Peter
2024.
The emergence of antidepressant drugs targeting GABAA receptors: A concise review.
Biochemical Pharmacology,
Vol. 228,
Issue. ,
p.
116481.
Cha, Danielle S.
Kleine, Nicholas
Teopiz, Kayla M.
Di Vincenzo, Joshua D.
Ho, Roger
Galibert, Stephanie L.
Samra, Amrita
Zilm, Samuel P.M.
Cha, Rebekah H.
d’Andrea, Giacomo
Gill, Hartej
Ceban, Felicia
Meshkat, Shakila
Wong, Sabrina
Le, Gia Han
Kwan, Angela T.H
Rosenblat, Joshua D.
Rhee, Taeho Greg
Mansur, Rodrigo B.
and
McIntyre, Roger S.
2024.
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis.
Expert Opinion on Pharmacotherapy,
p.
1.